howev
identifi
ctl
epitop
deriv
hbv
genotyp
defin
viru
genotyp
b
c
preval
asia
hbv
core
protein
hbc
conserv
immunogen
compon
studi
use
overlap
peptid
pool
cover
hbc
screen
identifi
specif
ctl
epitop
unconvent
epitop
discov
structur
character
crystal
analysi
immunogen
antihbv
activ
determin
hbv
transgen
mice
final
show
mutat
epitop
associ
viral
paramet
diseas
progress
hbv
infect
patient
data
therefor
provid
insight
structur
characterist
unconvent
epitop
bind
mhci
molecul
well
epitop
specif
ctl
activ
orchestr
cell
respons
immun
evas
hbv
infect
patient
around
million
peopl
worldwid
chronic
infect
hepat
b
viru
hbv
chronic
hbv
infect
major
caus
cirrhosi
liver
failur
hepatocellular
carcinoma
hcc
lavanchi
neuveut
et
al
hbvspecif
lymphocyt
ctl
mediat
immun
respons
multispecif
polyclon
vigor
acut
hepat
b
ahb
play
vital
role
viral
control
viral
clearanc
well
diseas
pathogenesi
yukihiro
westov
hugh
tan
et
al
wherea
hbvspecif
ctl
respons
minim
undetect
chronic
hepat
b
chb
viral
persist
immun
toler
indic
key
role
hbvspecif
tcell
respons
determin
diseas
progress
outcom
bertoletti
gehr
hbv
genom
kb
length
effici
encod
sever
overlap
viral
protein
includ
polymeras
core
hbe
envelop
x
protein
analysi
ctl
specif
viral
epitop
within
core
sendi
et
al
liu
et
al
envelop
liu
et
al
polymeras
rehermann
et
al
x
hwang
et
al
protein
show
highli
conserv
hbv
core
protein
hbc
elicit
strongest
ctl
respons
viral
protein
suggest
hbcspecif
cell
respons
may
play
lead
role
viral
control
clearanc
identifi
immunedomin
hbvspecif
ctl
epitop
especi
epitop
hbc
protein
therefor
necessari
monitor
cell
respons
diseas
progress
well
develop
epitopebas
therapeut
vaccin
chb
inchausp
michel
gordon
et
al
liu
et
al
b
far
hbvspecif
human
leukocyt
antigen
hla
class
restrict
hbvspecif
hla
class
ii
restrict
epitop
identifi
hbv
genotyp
desmond
et
al
liu
et
al
guo
et
al
chen
et
al
tan
et
al
howev
identifi
epitop
deriv
hbv
genotyp
hla
class
restrict
epitop
defin
viru
genotyp
b
c
preval
asia
meanwhil
current
mostli
use
method
predict
identifi
cell
epitop
either
comput
algorithm
base
mode
peptid
bind
mhc
molecul
measur
cell
respons
pbmc
simul
panel
overlap
peptid
liu
et
al
epitop
identif
strategi
may
ignor
unconvent
cell
epitop
comput
analysi
larg
base
characterist
anchor
residu
studi
overlap
peptid
pool
use
screen
identifi
hbv
genotyp
band
cderiv
cell
epitop
new
unconvent
cell
epitop
deriv
viral
core
protein
share
partial
sequenc
ident
previous
report
bertoni
et
al
lee
et
al
discov
immunolog
function
clinic
relev
assess
identif
new
hlaa
epitop
hbv
core
protein
hbv
core
protein
conserv
immunogen
compon
hbv
protein
use
overlap
peptid
pool
cover
whole
length
core
protein
aa
variant
total
peptid
bind
assay
screen
genotyp
band
c
virusderiv
hbcagspecif
cell
epitop
shown
fig
sever
peptid
found
high
affin
bind
hlaa
molecul
evidenc
fi
shown
fig
span
hbc
aa
chosen
focu
studi
due
high
bind
affin
among
top
hit
screen
determin
minim
sequenc
length
epitop
panel
ctermin
truncat
extend
peptid
synthes
fi
truncat
peptid
stlpettv
tlpettvv
respect
fig
fi
decapeptid
lstlpettvv
stlpettvvr
respect
fig
truncat
extend
peptid
display
littl
bind
hlaa
indic
peptid
optim
epitop
length
addit
cell
bind
assay
capabl
bind
hlaa
observ
refold
assay
fig
structur
hlaa
complex
next
complex
prepar
crystal
character
bind
featur
crystal
structur
hla
complex
determin
resolut
tabl
structur
hlaa
show
possess
typic
conform
epitop
fig
unambigu
electron
densiti
clearli
show
posit
posit
buri
pocket
b
f
respect
fig
compar
typic
epitop
anchor
residu
leu
met
posit
thr
posit
side
chain
oh
thr
disrupt
insert
hydrophob
pocket
b
properli
fig
instead
side
chain
oh
thr
form
strong
hydrogen
bond
interact
h
atom
glu
domain
heavi
chain
help
bind
heavi
chain
stabil
entir
complex
side
chain
amino
acid
protrud
surfac
may
involv
cell
receptor
tcr
attach
recognit
best
knowledg
first
structur
show
bind
featur
unconvent
anchor
thr
peptid
gener
specif
ctl
respons
transgen
mice
immunogen
epitop
determin
vivo
femal
transgen
mice
immun
hbc
peptid
boost
regimen
three
time
use
heat
shock
protein
adjuv
li
et
al
ctl
detect
elispot
assay
week
last
immun
seen
fig
similar
peptideimmun
mice
posit
control
strong
ctl
respons
observ
splenocyt
peptideimmun
mice
sfc
peptidespecif
cell
respons
detect
peptideimmun
mice
neg
control
similar
result
observ
kill
assay
use
hbv
plasmidtransfect
cell
fig
peptidepuls
cell
fig
target
cell
determin
epitopespecif
ctl
fresh
pbmc
ahb
patient
stimul
peptid
detect
ex
vivo
elispot
assay
shown
fig
much
higher
peptidespecif
ctl
respons
observ
pbmc
stimul
immunodomin
peptid
posit
control
neg
control
peptid
vs
p
high
standard
deviat
observ
elispot
assay
may
reflect
random
betweenpati
variat
taken
togeth
result
indic
tcell
epitop
natur
process
patient
hbv
infect
epitop
elicit
antivir
cell
immun
transgen
mice
next
examin
whether
epitop
abl
induc
antihbv
cell
respons
use
hybrid
hbv
transgen
balbc
mice
transgen
mice
experiment
model
hbv
immunotoler
transgen
mice
immun
hbc
dna
prime
peptid
boost
formul
shown
fig
compar
mice
immun
neg
control
peptid
number
sfc
increas
around
peptideimmun
mice
similar
result
obtain
cytotox
assay
use
hbv
plasmidtransfect
cell
target
cell
evalu
peptideinduc
tcell
respons
could
lead
inhibit
hbv
immun
led
decreas
serum
hbsag
level
p
fig
signific
reduct
viral
dna
level
p
fig
week
compar
neg
control
meanwhil
signific
lower
level
serum
hbsag
viral
dna
observ
immun
week
immun
week
mice
control
peptidetr
mice
result
indic
epitopespecif
ctl
respons
induc
could
significantli
inhibit
hbv
replic
transgen
mice
vitro
refold
peptid
hlaa
heavi
chain
gel
filtrat
chromatographi
use
analyz
refold
complex
column
hla
complex
expect
molecular
mass
kda
elut
volum
ml
hla
complex
peak
analyz
sdspage
electrophoresi
coomassi
blue
stain
line
final
address
clinic
relev
epitop
chb
mutat
within
epitop
analyz
chb
aclf
patient
tabl
chb
compar
patient
infect
wildtyp
isol
stlpettvv
patient
infect
mutant
much
higher
alt
level
vs
p
fig
aspart
aminotransferas
ast
level
vs
p
fig
notabl
compar
chb
patient
infect
wildtyp
virus
patient
mutant
much
higher
approxim
hbv
dna
load
p
fig
statist
differ
sex
age
patient
infect
wildtyp
mutant
isol
preval
mutat
increas
diseas
progress
hbvinfect
patient
fig
investig
impact
sequenc
variat
within
epitop
immunogen
three
peptid
contain
main
epitop
variat
chb
patient
synthes
respect
transgen
mice
immun
seen
fig
compar
wildtyp
peptideimmun
mice
sfc
ctl
respons
elispot
assay
significantli
decreas
mutant
peptid
sfc
mutant
peptideimmun
mice
sfc
taken
togeth
result
suggest
mutat
associ
necroinflamm
higher
hbv
level
may
also
associ
poor
prognosi
may
due
viral
immun
evas
studi
identifi
new
cell
epitop
screen
overlap
peptid
pool
cover
hbv
core
protein
unconvent
restrict
epitop
determin
structur
character
transgen
mous
model
crystallograph
analysi
moreov
demonstr
epitop
exhibit
antivir
capabl
transgen
mice
final
result
show
mutat
epitop
correl
clinic
relev
paramet
chb
work
may
therefor
provid
comprehens
evalu
impact
newli
defin
epitop
viral
specif
cell
respons
suggest
possibl
immun
evas
mainten
viral
persist
patient
hbv
infect
identif
hbvspecif
cell
epitop
mostli
base
bind
mode
peptid
mhc
molecul
silico
predict
assess
cell
respons
panel
overlap
peptid
hbvinfect
patient
method
effect
rapid
purpos
identifi
epitop
howev
consider
number
atyp
unconvent
epitop
may
ignor
miss
method
due
limit
anchor
residu
analysisbas
comput
liu
et
al
studi
overlap
peptid
pool
use
screen
b
c
genotypederiv
hbcspecif
ctl
epitop
identifi
new
cell
epitop
importantli
similar
number
immunodomin
epitop
cell
observ
ahb
patient
fig
indic
immunodomin
epitop
hbvinfect
patient
howev
newli
defin
epitop
stlpettvv
studi
possess
thr
posit
differ
cell
epitop
predict
program
includ
syfpeithi
http
wwwsyfpeithi
descriptsmhcserverdllepitopepredictionhtm
netmhc
http
wwwcbsdtudkservicesnetmhc
bima
http
wwwbimascitnihgov
show
bind
score
epitop
respect
get
high
score
could
omit
convent
screen
interestingli
stlpettvv
side
chain
oh
form
stronger
hydrogen
bond
interact
glu
domain
heavi
chain
help
insert
lu
sun
et
al
pocket
b
fig
hlaa
stabil
entir
complex
therefor
data
indic
thr
may
also
act
domin
role
anchor
peptid
may
taken
consider
futur
design
onlin
predict
program
cell
main
effector
cell
respons
viral
clearanc
well
diseas
pathogenesi
hbv
infect
thimm
et
al
harari
et
al
ouyang
et
al
consequ
longterm
interact
hbv
infect
patient
viru
evolv
mutat
reduc
epitop
evad
immun
detect
clearanc
especi
escap
cell
recognit
maman
et
al
westov
hugh
inde
nonsynonym
mutat
hbv
epitop
found
associ
diseas
progress
chb
kim
et
al
frelin
et
al
consist
studi
found
mutat
newli
defin
epitop
posit
relat
viral
paramet
pathogenesi
liver
diseas
effect
mutat
within
viral
replic
capabl
well
potenti
impact
epitopespecif
ctl
interplay
hbv
chronic
infect
patient
remain
address
summari
studi
indic
immunodomin
ctl
epitop
atyp
bind
characterist
molecul
potent
antihbv
immun
activ
clinic
signific
patient
hbv
infect
demonstr
mutat
within
epitop
may
affect
diseas
progress
chb
given
key
role
cell
viral
clearanc
work
provid
valuabl
insight
function
implic
epitopespecif
cell
respons
hbv
infect
understand
epitopespecif
ctl
function
complex
regul
network
orchestr
cell
respons
viral
persist
immunoevas
chb
allow
predict
diseas
progress
develop
immunotherapeut
approach
hbv
infect
enrol
patient
clinic
characterist
describ
tabl
total
ahb
patient
enrol
blood
collect
divid
two
group
n
n
patient
neg
hcv
hdv
infect
ml
blood
sampl
collect
patient
patient
hospit
beij
hospit
septemb
septemb
studi
particip
written
inform
consent
studi
approv
ethic
committe
beij
hospit
hbv
transgen
balbc
mice
purchas
transgen
engin
lab
infecti
diseas
center
guangzhou
china
gener
viral
dna
construct
contain
copi
hbv
genom
serum
hbv
antigen
hbsag
viral
dna
well
hbc
express
hepatocyt
mice
liver
test
posit
transgen
mice
transgen
mice
zhang
et
al
cell
label
cfse
load
peptid
h
target
cell
c
target
cell
mix
splenocyt
differ
ratio
splenocyt
serv
posit
neg
control
h
mix
sampl
stain
pi
kill
target
cell
analyz
fac
data
shown
mean
sd
five
mice
ahb
patient
n
divid
n
n
group
pbmc
well
patient
stimul
indic
peptid
detect
peptidespecif
ctl
elispot
assay
peptid
serv
neg
control
background
evalu
elispot
assay
pbmc
use
specif
evalu
ctl
pair
sampl
ttest
use
elispot
assay
ahb
patient
p
p
ttest
data
repres
two
independ
experi
professor
huang
wl
imca
beij
china
mice
hbv
transgen
mice
cross
gain
hybrid
transgen
mice
hybrid
screen
serum
hbsag
elisa
viral
dna
realtim
pcr
pcrssp
protran
deutschland
experiment
manipul
wildtyp
hbc
gene
clone
invitrogen
recombin
plasmid
design
contain
copi
fulllength
hbv
genom
sequenc
maintain
lab
hbc
sequenc
genotyp
b
c
attain
use
protein
databas
ncbi
total
hbc
sequenc
genotyp
b
hbc
sequenc
genotyp
c
includ
sequenc
compar
serv
basi
peptid
synthesi
variat
rate
certain
amino
acid
aa
seri
peptid
associ
variat
would
synthes
adopt
overlap
method
overlap
synthes
total
nonapeptid
cover
aa
peptid
synthes
jier
biolog
shanghai
china
puriti
determin
flpsdffpsv
relvvsyvn
peptid
use
posit
neg
control
respect
fig
fresh
splenocyt
isol
immun
mice
stimul
wildtyp
mutant
peptid
respect
peptidespecif
ctl
detect
elispot
assay
manufactur
cell
supernat
harvest
h
h
h
transfect
respect
cell
use
perform
mhc
stabil
assay
previous
describ
zhou
et
al
bind
activ
peptid
calcul
fluoresc
index
fi
fi
determin
mean
fitc
fluoresc
given
peptid
mean
fitc
fluoresc
without
peptid
mean
fitc
fluoresc
without
peptid
peptid
regard
epitop
high
affin
meet
follow
criteria
fi
refold
protein
crystallographi
structur
determin
recombin
protein
hlaa
heavi
chain
express
escherichia
coli
garboczi
et
al
gradual
dilut
method
perform
refold
process
liu
et
al
superdex
gl
gel
filtrat
chromatographi
follow
resourceq
anionexchang
chromatographi
ge
healthcar
use
concentr
purif
solubl
portion
refold
complex
hangingdrop
vapor
diffus
method
perform
crystal
purifi
complex
final
concentr
mgml
moll
bistri
ph
wv
polyethylen
glycol
crystal
obtain
equip
raxi
v
imagepl
detector
rigaku
rotatinganod
xray
gener
oper
kv
cu
collect
crystallograph
data
k
hous
protein
data
bank
pdb
entri
search
model
structur
hlaa
determin
molecular
replac
program
molrep
mice
week
old
immun
im
plasmid
control
week
subcutan
peptid
bound
heat
shock
protein
adjuv
li
et
al
week
respect
mice
sacrif
week
last
immun
splenocyt
isol
previous
describ
liu
et
al
group
contain
five
seven
mice
detect
epitopespecif
cell
enzymelink
immunosorb
spot
elispot
assay
perform
accord
manufactur
instruct
briefli
ninetysix
well
pvdf
plate
bdpharmigen
san
diego
ca
precoat
overnight
coat
ab
block
h
patient
pbmc
murin
splenocyt
ad
well
togeth
peptid
incub
h
phytohemagglutinin
pha
stimul
cell
posit
control
test
perform
least
triplic
spot
count
analyz
use
elispot
reader
cellular
technolog
ltd
usa
cell
label
cfse
target
cell
transfect
seed
plate
ctl
ad
differ
ratio
plate
incub
h
cfse
posit
target
cell
stain
propidium
iodid
pi
use
vybrant
apoptosi
assay
kit
invitrogen
usa
addit
cell
load
peptid
h
target
cell
seed
plate
cytotox
assay
perform
describ
assay
perform
triplic
detect
hbsag
hbeag
elisa
hbv
dna
realtim
pcr
elisa
realtim
pcr
detect
serum
hbsag
hbeag
viral
dna
copi
perform
describ
fan
et
al
differ
group
determin
use
student
ttest
pearson
test
use
detect
correl
variat
rate
diseas
progress
hbv
infect
patient
clinic
statist
analys
perform
spss
version
softwar
spss
inc
chicago
illinoi
p
valu
consid
signific
